Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection

Journal: Nature Medicine

Published: 2021-06-07

DOI: 10.1038/s41591-021-01371-0

Affiliations: 95

Authors: 402

Go to article
Institutions Share
Institute for Molecular Medicine Finland (FIMM), Finland 0.13
The Hospital District of Helsinki and Uusimaa (HUS), Finland 0.07
National Institute for Health and Welfare (THL), Finland 0.05
GlaxoSmithKline plc. (GSK), United Kingdom (UK) 0.04
Hospital District of Southwest Finland, Finland 0.04
AbbVie Inc., United States of America (USA) 0.04
Northern Ostrobothnia Hospital District (NOHD), Finland 0.04
Northern Savo Hospital District, Finland 0.04
Genentech, Inc., United States of America (USA) 0.03
Biogen Inc., United States of America (USA) 0.03
Pirkanmaa Hospital District, Finland 0.03
Pfizer Inc., United States of America (USA) 0.03
Sanofi, France 0.03
Novartis International AG, Switzerland 0.02
Broad Institute of MIT and Harvard, United States of America (USA) 0.02
Merck & Co., Inc., United States of America (USA) 0.02
AstraZeneca Cambridge, United Kingdom (UK) 0.02
The University of Tokyo (UTokyo), Japan 0.01
Tampere University, Finland 0.01
Celgene Corporation, United States of America (USA) 0.01
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA) 0.01
Brigham and Women's Hospital (BWH), United States of America (USA) 0.01
Auria Biobank, Finland 0.01
Helsinki Biobank, Finland 0.01
Northern Finland Biobank Borealis, Finland 0.01
Finnish Biobank Cooperative (FINBB), Finland 0.01
Bristol-Myers Squibb (BMS), United States of America (USA) 0.01
Massachusetts General Hospital (MGH), United States of America (USA) 0.01
NIH National Cancer Institute (NCI), United States of America (USA) 0.01
Maze Therapeutics, United States of America (USA) 0.01
Yale University, United States of America (USA) 0.01
Janssen Pharmaceutica, Belgium 0.01
University of Turku (UTU), Finland 0.01
Finnish Clinical Biobank Tampere (FCBT), Finland 0.01
University of Helsinki, Finland 0.01
University of Oulu, Finland 0.01
RIKEN Center for Integrative Medical Sciences (IMS), Japan 0.01
Central Finland Biobank, Finland 0.01
Finnish Red Cross Blood Service, Finland 0.01
RIKEN Laboratory for Statistical and Translational Genetics, Japan 0.01
Juntendo University, Japan 0
Nihon University, Japan 0
Tokushukai Group, Japan 0
Nippon Medical School, Japan 0
Business Finland, Finland 0
Harvard University, United States of America (USA) 0
Columbia University in the City of New York (CU), United States of America (USA) 0
Finnish Hematology Registry and Clinical Biobank (FHRB Biobank), Finland 0
Stanford University, United States of America (USA) 0
University of Jyväskylä, Finland 0
National Hospital Organization Osaka National Hospital, Japan 0
University of Eastern Finland (UEF), Finland 0
Biobank of Eastern Finland, Finland 0
Iizuka Hospital, Japan 0
IMSUT Hospital, UTokyo, Japan 0
Iwate Medical University, Japan 0
Tokyo Metropolitan Geriatric Hospital, Japan 0
Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan 0
Cancer Institute Hospital, JFCR, Japan 0
Shiga University of Medical Science (SUMS), Japan 0
Osaka International Cancer Institute, Japan 0
Partners HealthCare, United States of America (USA) 0
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0
Vertex Pharmaceuticals Incorporated, United States of America (USA) 0
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0
University of Shizuoka, Japan 0
Shizuoka General Hospital, Japan 0
Howard Hughes Medical Institute (HHMI), United States of America (USA) 0

Return